Skip to main content

Table 4 Logistic regression analysis (survivors)

From: Impact of individual background on the unmet needs of cancer survivors and caregivers – a mixed-methods analysis

 

Odds ratio (95% Confidence interval)

 

Physical

Financial

Education/information

Personal Control

System of Care

Resources

Sex

 Male (reference)

 Female

2.50 (1.54–4.07)*

0.52 (0.22–1.21)

0.79 (0.54–1.15)

1.95 (0.59–6.42)

1.19 (0.47–3.05)

0.62 (0.43–0.91)*

Age group (in years)

< 40, 40–59, 60–69, ≥ 70

1.25 (1.00–1.57)

1.03 (0.70–1.51)

0.94 (0.78–1.13)

0.80 (0.46–1.39)

0.77 (0.49–1.22)

0.98 (0.81–1.18)

Cancer type

Breast (reference)

 Colon

1.05 (0.52–2.10)

0.52 (0.15–1.81)

1.11 (0.59–2.08)

0.59 (0.07–5.12)

1.99 (0.44–9.08)

1.34 (0.70–2.60)

 Lung

0.72 (0.31–1.69)

0.15 (0.02–1.31)

1.72 (0.87–3.43)

0.78 (0.09–7.02)

0.85 (0.09–7.93)

1.39 (0.67–2.87)

 Stomach

0.96 (0.44–2.10)

0.27 (0.05–1.40)

1.27 (0.63–2.58)

1.94 (0.34–11.00)

1.56 (0.26–9.24)

1.49 (0.73–3.03)

 Other

0.78 (0.45–1.33)

0.53 (0.20–1.35)

1.11 (0.69–1.81)

1.17 (0.35–3.95)

1.56 (0.47–5.20)

1.23 (0.74–2.04)

 Multi primary

2.33 (0.85–6.43)

0.35 (0.04–2.94)

0.49 (0.16–1.53)

3.97 (0.67–23.40)

1.95 (0.21–18.40)

1.25 (0.47–3.31)

 Never diagnosed with cancer

0.41 (0.17–0.97)*

0.25 (0.06–0.98)*

1.77 (1.00–3.13)

0.00 (0.00-Inf)

1.83 (0.47–7.20)

1.40 (0.77–2.54)

Treatment course

Pretreatment (reference)

 Ongoing

5.08 (2.64–9.78)*

0.71 (0.32–1.59)

1.28 (0.85–1.93)

1.31 (0.43–3.96)

0.70 (0.25–1.98)

0.51 (0.34–0.78)*

 Completed

5.35 (2.74–10.40)*

0.91 (0.41–2.06)

0.78 (0.52–1.18)

0.28 (0.05–1.47)

0.69 (0.26–1.80)

0.68 (0.46–1.01)

Residence

CDOa (reference)

 Within KPb

1.12 (0.74–1.70)

0.85 (0.42–1.73)

0.75 (0.53–1.07)

1.19 (0.44–3.22)

1.44 (0.64–3.25)

1.16 (0.82–1.65)

 Outside KPb

0.22 (0.06–0.79)*

0.80 (0.18–3.58)

0.90 (0.45–1.78)

1.67 (0.34–8.25)

0.64 (0.08–5.12)

1.51 (0.78–2.95)

Symptom

Yes (reference)

 No

8.69 (5.35–14.10)*

0.67 (0.35–1.29)

0.46 (0.33–0.64)*

0.99 (0.38–2.59)

0.79 (0.35–1.76)

0.69 (0.50–0.96)*

Past consultation history at KCCc

 Yes (reference)

 No

1.22 (0.65–2.28)

1.91 (0.75–4.81)

1.18 (0.68–2.06)

0.53 (0.07–4.16)

0.91 (0.21–4.00)

0.54 (0.27–1.07)

 

Emotions/Mental Health

Social Support

Communications

Provider Relationship

Cure

Employment

Sex

 Male (reference)

      

 Female

1.60 (1.05–2.43)*

1.76 (0.38–8.23)

1.81 (0.80–4.08)

1.25 (0.72–2.17)

0.77 (0.51–1.15)

0.34 (0.10–1.21)

Age group (in years)

      

  < 40, 40–59, 60–69, ≥ 70

0.95 (0.78–1.16)

1.30 (0.69–2.47)

1.18 (0.82–1.70)

0.98 (0.75–1.29)

1.03 (0.84–1.25)

0.37 (0.20–0.67)*

Cancer type

 Breast (reference)

      

 Colon

0.83 (0.43–1.62)

0.00 (0.00-Inf)

1.28 (0.48–3.41)

1.96 (0.86–4.48)

1.03 (0.52–2.04)

0.00 (0.00-Inf)

 Lung

0.73 (0.33–1.61)

0.00 (0.00-Inf)

0.46 (0.10–2.17)

1.88 (0.73–4.83)

1.46 (0.71–3.02)

0.27 (0.02–2.86)

 Stomach

0.93 (0.45–1.93)

0.41 (0.04–4.15)

0.46 (0.10–2.20)

1.17 (0.41–3.31)

1.13 (0.53–2.42)

0.17 (0.02–1.86)

 Other

0.91 (0.56–1.47)

0.43 (0.10–1.88)

0.63 (0.26–1.49)

1.16 (0.57–2.36)

1.14 (0.68–1.92)

0.61 (0.19–1.98)

 Multi primary

0.89 (0.33–2.40)

2.03 (0.32–13.00)

2.00 (0.57–7.00)

1.84 (0.55–6.18)

0.98 (0.35–2.73)

0.00 (0.00-Inf)

 Never diagnosed with cancer

1.52 (0.85–2.71)

0.27 (0.03–2.58)

0.31 (0.07–1.45)

1.43 (0.59–3.44)

1.01 (0.53–1.93)

0.00 (0.00-Inf)

Treatment course

 Pretreatment (reference)

      

 Ongoing

1.14 (0.72–1.79)

1.36 (0.32–5.78)

1.48 (0.66–3.31)

1.63 (0.86–3.09)

0.97 (0.63–1.48)

1.01 (0.29–3.55)

 Completed

1.23 (0.79–1.91)

1.42 (0.31–6.46)

0.68 (0.26–1.73)

1.26 (0.66–2.42)

0.53 (0.34–0.82)*

2.72 (0.86–8.57)

Residence

 CDOa (reference)

      

 Within KPb

1.18 (0.82–1.70)

0.30 (0.07–1.38)

1.20 (0.63–2.30)

1.18 (0.71–1.94)

1.20 (0.83–1.74)

1.03 (0.41–2.58)

 Outside KPb

0.79 (0.35–1.79)

1.01 (0.12–8.62)

0.39 (0.05–3.02)

0.85 (0.29–2.54)

1.92 (0.98–3.75)

0.00 (0.00-Inf)

Symptom

 Yes (reference)

      

 No

1.78 (1.25–2.53)*

1.21 (0.41–3.61)

1.31 (0.70–2.46)

1.49 (0.92–2.42)

0.56 (0.40–0.79)*

1.59 (0.62–4.10)

Past consultation history at KCCc

 Yes (reference)

      

 No

0.85 (0.47–1.55)

0.00 (0.00-Inf)

1.13 (0.42–3.03)

0.62 (0.24–1.60)

0.31 (0.13–0.74)*

0.44 (0.05–3.48)

  1. *p < 0.05, aA city designated by official ordinance, bKanagawa prefecture, cKanagawa Cancer Center